ALK+ ALCL should be distinguished from ALK+ large B-cell lymphomas and nonhematopoietic neoplasms expressing ALK such as inflammatory myofibroblastic tumors, rhabdomyosarcomas, and neuroblastomas [29,118,119]. This evidence concerns the gene ALK and inflammatory myofibroblastic tumor.